Company: CMND
Filing Date: 2025-01-22
Form Type: 20-F
Source: 0001213900-25-005490
Chunk: 76

Company: Clearmind Medicine Inc.
Filing Date: 2025-01-22
Form: 20-F
Item: Item 3
Chunk 76
---
ship disputes arise from
conflicting obligations of consultants or others who are involved in developing our product candidates. Litigation may be necessary to
defend against these and other claims challenging inventorship or claiming the right to compensation. If we fail in defending any such
claims, in addition to paying monetary damages, we may lose valuable intellectual property rights, such as exclusive ownership of, or
right to use, valuable intellectual property. Such an outcome could have a material adverse effect on our business. Even if we are successful
in defending against such claims, litigation could result in substantial costs and be a distraction to management and other employees.
To the extent that our employees have not effectively waived the right to compensation with respect to inventions that they helped create,
they may be able to assert claims for compensation with respect to our future revenue. As a result, we may receive less revenue from future
products if such claims are successful which in turn could impact our future profitability.

Changes in United States and international patent law could diminish
the value of patents in general, thereby impairing our ability to protect our products.

Our success is heavily dependent on intellectual
property. Obtaining and enforcing patents in the pharmaceutical industry involves both technological and legal complexity. Therefore,
obtaining and enforcing these patents is costly, time consuming and inherently uncertain. In addition, the United States has recently
enacted and is currently implementing wide-ranging patent reform legislation. Recent United States Supreme Court rulings have narrowed
the scope of patent protection available in certain circumstances and weakened the rights of patent owners in certain situations. In addition
to increasing uncertainty with regard to our ability to obtain patents in the future, this combination of events has created uncertainty
with respect to the value of patents, once obtained. Depending on future actions by the United States Congress, the federal courts and
the USPTO, the laws and regulations governing patents could change in unpredictable ways that would weaken our ability to obtain patents
or to enforce patents that we might obtain in the future.

We may not be able to protect our intellectual property rights throughout
the world.

Filing, prosecuting and defending patents on product
candidates in all countries throughout the world would be prohibitively expensive, and our intellectual property rights in some countries
outside the United States may be less extensive than those in the United States. In addition, the laws of some foreign countries do not
protect intellectual property rights to the same extent as federal and state laws in the United States.

Competitors may use our technologies in jurisdictions
where we have not obtained patent